HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tse, A. Articles by Moran, R. G. Search for Related Content PubMed PubMed Citation Articles by Tse, A. Articles by Moran, R. G. Social Bookmarking                      What's this?

J Biol Chem, Vol. 273, Issue 40, 25944-25952, October 2, 1998

Cellular Folates Prevent Polyglutamation of 5,10-Dideazatetrahydrofolate
A NOVEL MECHANISM OF RESISTANCE TO FOLATE ANTIMETABOLITES

From the Department of Biochemistry and Molecular Biology, University of Southern California, Los Angeles, California 90033 and the Department of Pharmacology and Toxicology and the Massey Cancer Center, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia 23298-0230

Mouse L1210 cell variants were selected for resistance to 5,10-dideazatetrahydrofolate, a potent inhibitor of the first folate-dependent enzyme in de novo purine synthesis, glycinamide ribonucleotide formyltransferase. The drug-resistant phenotype selected was conditional to the folate compound used to support growth: grown on folic acid cells were 400-fold resistant, whereas they were 2.5-fold more sensitive to 5,10-dideazatetrahydrofolate than wild-type L1210 cells when grown on folinic acid. In folic acid-containing media, polyglutamation of 5,10-dideazatetrahydrofolate was markedly reduced, yet folylpolyglutamate synthetase activity was not different from that in parental L1210 cells. Resistance was due to two changes in membrane transport: a minor increase in the K_m for 5,10-dideazatetrahydrofolate influx, and a major increase in folic acid transport. Enhanced folic acid transport resulted in an expanded cellular content of folates which blocked polyglutamation of 5,10-dideazatetrahydrofolate.

We propose that polyglutamation of 5,10-dideazatetrahydrofolate is limited by feedback inhibition by cellular folates on folylpolyglutamate synthetase, an effect which reflects a mechanism in place to control the level of cellular folates. Although the primary alteration causative of resistance is different from those reported previously, all 5,10-dideazatetrahydrofolate resistance phenotypes result in decreased drug polyglutamation, reflecting the centrality of this reaction to the action of 5,10-dideazatetrahydrofolate.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				R. C. Cho, P. D. Cole, K.-J. Sohn, G. Gaisano, R. Croxford, B. A. Kamen, and Y.-I. Kim Effects of folate and folylpolyglutamyl synthase modulation on chemosensitivity of breast cancer cells Mol. Cancer Ther., November 1, 2007; 6(11): 2909 - 2920. [Abstract] [Full Text] [PDF]

				R. Zhao, S. Zhang, M. Hanscom, S. Chattopadhyay, and I. D. Goldman Loss of Reduced Folate Carrier Function and Folate Depletion Result in Enhanced Pemetrexed Inhibition of Purine Synthesis Clin. Cancer Res., February 1, 2005; 11(3): 1294 - 1301. [Abstract] [Full Text] [PDF]

				R. Zhao, S. Chattopadhyay, M. Hanscom, and I. D. Goldman Antifolate Resistance in a HeLa Cell Line Associated With Impaired Transport Independent of the Reduced Folate Carrier Clin. Cancer Res., December 15, 2004; 10(24): 8735 - 8742. [Abstract] [Full Text] [PDF]

				K-J Sohn, F Smirnakis, D N Moskovitz, P Novakovic, Z Yates, M Lucock, R Croxford, and Y-I Kim Effects of folylpolyglutamate synthetase modulation on chemosensitivity of colon cancer cells to 5-fluorouracil and methotrexate Gut, December 1, 2004; 53(12): 1825 - 1831. [Abstract] [Full Text] [PDF]

				M. Stark, L. Rothem, G. Jansen, G. L. Scheffer, I. D. Goldman, and Y. G. Assaraf Antifolate Resistance Associated with Loss of MRP1 Expression and Function in Chinese Hamster Ovary Cells with Markedly Impaired Export of Folate and Cholate Mol. Pharmacol., August 1, 2003; 64(2): 220 - 227. [Abstract] [Full Text] [PDF]

				J. Worm, A. F. Kirkin, K. N. Dzhandzhugazyan, and P. Guldberg Methylation-dependent Silencing of the Reduced Folate Carrier Gene in Inherently Methotrexate-resistant Human Breast Cancer Cells J. Biol. Chem., October 19, 2001; 276(43): 39990 - 40000. [Abstract] [Full Text] [PDF]

				X. Lu, J. Errington, V. J. Chen, N. J. Curtin, A. V. Boddy, and D. R. Newell Cellular ATP Depletion by LY309887 as a Predictor of Growth Inhibition in Human Tumor Cell Lines Clin. Cancer Res., January 1, 2001; 6(1): 271 - 277. [Abstract] [Full Text]

				R. Zhao, F. Gao, S. Babani, and I. D. Goldman Sensitivity to 5,10-Dideazatetrahydrofolate Is Fully Conserved in a Murine Leukemia Cell Line Highly Resistant to Methotrexate Due to Impaired Transport Mediated by the Reduced Folate Carrier Clin. Cancer Res., August 1, 2000; 6(8): 3304 - 3311. [Abstract] [Full Text]

				R. Zhao, F. Gao, P. J. Wang, and I. D. Goldman Role of the Amino Acid 45 Residue in Reduced Folate Carrier Function and Ion-Dependent Transport as Characterized by Site-Directed Mutagenesis Mol. Pharmacol., February 1, 2000; 57(2): 317 - 323. [Abstract] [Full Text]

				F. M. Sirotnak RESPONSE: Re: Folylpolyglutamyl Synthetase Gene Transfer and Glioma Antifolate Sensitivity in Culture and In Vivo J Natl Cancer Inst, December 1, 1999; 91(23): 2049 - 2050. [Full Text] [PDF]

				G. Jansen, G. J. Peters, H. M. Pinedo, D. G. Priest, and Y. G. Assaraf Re: Folylpolyglutamyl Synthetase Gene Transfer and Glioma Antifolate Sensitivity in Culture and In Vivo J Natl Cancer Inst, December 1, 1999; 91(23): 2047a - 2048a. [Full Text] [PDF]

				F. B. Turner, J. L. Andreassi II, J. Ferguson, S. Titus, A. Tse, S. M. Taylor, and R. G. Moran Tissue-specific Expression of Functional Isoforms of Mouse Folylpoly-{{gamma}}-glutamate Synthetase: A Basis for Targeting Folate Antimetabolites Cancer Res., December 1, 1999; 59(24): 6074 - 6079. [Abstract] [Full Text] [PDF]

				B. van Triest, H. M. Pinedo, Y. van Hensbergen, K. Smid, F. Telleman, P. S. Schoenmakers, C. L. van der Wilt, J. A. M. van Laar, P. Noordhuis, G. Jansen, et al. Thymidylate Synthase Level as the Main Predictive Parameter for Sensitivity to 5-Fluorouracil, but not for Folate-based Thymidylate Synthase Inhibitors, in 13 Nonselected Colon Cancer Cell Lines Clin. Cancer Res., March 1, 1999; 5(3): 643 - 654. [Abstract] [Full Text] [PDF]

				A. Tse, K. Brigle, S. M. Taylor, and R. G. Moran Mutations in the Reduced Folate Carrier Gene Which Confer Dominant Resistance to 5,10-Dideazatetrahydrofolate J. Biol. Chem., October 2, 1998; 273(40): 25953 - 25960. [Abstract] [Full Text] [PDF]

				R. Zhao, S. Titus, F. Gao, R. G. Moran, and I. D. Goldman Molecular Analysis of Murine Leukemia Cell Lines Resistant to 5,10-Dideazatetrahydrofolate Identifies Several Amino Acids Critical to the Function of Folylpolyglutamate Synthetase J. Biol. Chem., August 18, 2000; 275(34): 26599 - 26606. [Abstract] [Full Text] [PDF]

				S. Drori, G. Jansen, R. Mauritz, G. J. Peters, and Y. G. Assaraf Clustering of Mutations in the First Transmembrane Domain of the Human Reduced Folate Carrier in GW1843U89-resistant Leukemia Cells with Impaired Antifolate Transport and Augmented Folate Uptake J. Biol. Chem., September 29, 2000; 275(40): 30855 - 30863. [Abstract] [Full Text] [PDF]